Spanish Red Biotech Pipeline

MSD

Pembrolizumab/Olaparib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Phase III first line chemotherapy plus pembrolizumab + olaparib for BRCA non-mutated advanced EOC (epitelial ovarian cancer)
Phase: 3Phase III in Spain, 2Phase II, 1Phase I